First Time Loading...
C

China Isotope & Radiation Corp
HKEX:1763

Watchlist Manager
China Isotope & Radiation Corp
HKEX:1763
Watchlist
Price: 10.32 HKD 4.45% Market Closed
Updated: Apr 23, 2024
Section:
 

Intrinsic Value

China Isotope & Radiation Corp. engages in the research, development, manufacturing and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products for medical and industri... [ Read More ]

The intrinsic value of one China Isotope & Radiation Corp stock under the Base Case scenario is 21.94 HKD. Compared to the current market price of 10.32 HKD, China Isotope & Radiation Corp is Undervalued by 53%.

Key Points:
Intrinsic Value
Base Case
21.94 HKD
Undervaluation 53%
Intrinsic Value
Price
C
Worst Case
Base Case
Best Case
What is intrinsic value?

Valuation Backtest
China Isotope & Radiation Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling China Isotope & Radiation Corp stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
China Isotope & Radiation Corp

What unique competitive advantages
does China Isotope & Radiation Corp hold over its rivals?

What risks and challenges
does China Isotope & Radiation Corp face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of China Isotope & Radiation Corp.

Provide an overview of the primary business activities
of China Isotope & Radiation Corp.

What unique competitive advantages
does China Isotope & Radiation Corp hold over its rivals?

What risks and challenges
does China Isotope & Radiation Corp face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for China Isotope & Radiation Corp.

Provide P/S
for China Isotope & Radiation Corp.

Provide P/E
for China Isotope & Radiation Corp.

Provide P/OCF
for China Isotope & Radiation Corp.

Provide P/FCFE
for China Isotope & Radiation Corp.

Provide P/B
for China Isotope & Radiation Corp.

Provide EV/S
for China Isotope & Radiation Corp.

Provide EV/GP
for China Isotope & Radiation Corp.

Provide EV/EBITDA
for China Isotope & Radiation Corp.

Provide EV/EBIT
for China Isotope & Radiation Corp.

Provide EV/OCF
for China Isotope & Radiation Corp.

Provide EV/FCFF
for China Isotope & Radiation Corp.

Provide EV/IC
for China Isotope & Radiation Corp.

Show me price targets
for China Isotope & Radiation Corp made by professional analysts.

What are the Revenue projections
for China Isotope & Radiation Corp?

How accurate were the past Revenue estimates
for China Isotope & Radiation Corp?

What are the Net Income projections
for China Isotope & Radiation Corp?

How accurate were the past Net Income estimates
for China Isotope & Radiation Corp?

What are the EPS projections
for China Isotope & Radiation Corp?

How accurate were the past EPS estimates
for China Isotope & Radiation Corp?

What are the EBIT projections
for China Isotope & Radiation Corp?

How accurate were the past EBIT estimates
for China Isotope & Radiation Corp?

Compare the revenue forecasts
for China Isotope & Radiation Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of China Isotope & Radiation Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of China Isotope & Radiation Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of China Isotope & Radiation Corp compared to its peers.

Compare the P/E ratios
of China Isotope & Radiation Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing China Isotope & Radiation Corp with its peers.

Analyze the financial leverage
of China Isotope & Radiation Corp compared to its main competitors.

Show all profitability ratios
for China Isotope & Radiation Corp.

Provide ROE
for China Isotope & Radiation Corp.

Provide ROA
for China Isotope & Radiation Corp.

Provide ROIC
for China Isotope & Radiation Corp.

Provide ROCE
for China Isotope & Radiation Corp.

Provide Gross Margin
for China Isotope & Radiation Corp.

Provide Operating Margin
for China Isotope & Radiation Corp.

Provide Net Margin
for China Isotope & Radiation Corp.

Provide FCF Margin
for China Isotope & Radiation Corp.

Show all solvency ratios
for China Isotope & Radiation Corp.

Provide D/E Ratio
for China Isotope & Radiation Corp.

Provide D/A Ratio
for China Isotope & Radiation Corp.

Provide Interest Coverage Ratio
for China Isotope & Radiation Corp.

Provide Altman Z-Score Ratio
for China Isotope & Radiation Corp.

Provide Quick Ratio
for China Isotope & Radiation Corp.

Provide Current Ratio
for China Isotope & Radiation Corp.

Provide Cash Ratio
for China Isotope & Radiation Corp.

What is the historical Revenue growth
over the last 5 years for China Isotope & Radiation Corp?

What is the historical Net Income growth
over the last 5 years for China Isotope & Radiation Corp?

What is the current Free Cash Flow
of China Isotope & Radiation Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for China Isotope & Radiation Corp.

Popular Strategic Analysis Valuation Future Outlook Peer Analysis Profitability Solvency Financials
Financials
Revenue
Operating Income
Net Income
Operating Cash Flow
Investing Cash Flow
Financing Cash Flow

Balance Sheet Decomposition
China Isotope & Radiation Corp

13.2B
Assets
8.5B
Liabilities
13.2B
Assets
8.5B
Liabilities
Current Assets 8.2B
Cash & Short-Term Investments 2.9B
Receivables 3.9B
Other Current Assets 1.4B
Non-Current Assets 5B
Long-Term Investments 825.6m
PP&E 3.6B
Intangibles 293.6m
Other Non-Current Assets 276.9m
Current Liabilities 4.3B
Accounts Payable 626.7m
Accrued Liabilities 3.3B
Other Current Liabilities 371.3m
Non-Current Liabilities 4.2B
Long-Term Debt 1.5B
Other Non-Current Liabilities 2.8B
Efficiency

Earnings Waterfall
China Isotope & Radiation Corp

Revenue
6.6B CNY
Cost of Revenue
-3.2B CNY
Gross Profit
3.5B CNY
Operating Expenses
-2.5B CNY
Operating Income
941.7m CNY
Other Expenses
-570.8m CNY
Net Income
371m CNY
Gross Margin
Operating Margin
Net Margin
FCF Margin
ROE
ROA
ROIC
ROCE

Free Cash Flow Analysis
China Isotope & Radiation Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

Profitability Score
Profitability Due Diligence

China Isotope & Radiation Corp's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive Free Cash Flow
Positive Operating Income
55/100
Profitability
Score

China Isotope & Radiation Corp's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

China Isotope & Radiation Corp's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Low D/E
Negative Net Debt
Short-Term Solvency
69/100
Solvency
Score

China Isotope & Radiation Corp's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
China Isotope & Radiation Corp

Wall Street analysts forecast China Isotope & Radiation Corp stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for China Isotope & Radiation Corp is 33.56 HKD .

Lowest Forecast
Wall Street Target
Not Available
Average Forecast
Wall Street Target
33.56 HKD
225% Upside
Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
33.56 HKD
225% Upside
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

Price
China Isotope & Radiation Corp

1M 1M
-12%
6M 6M
-14%
1Y 1Y
-39%
3Y 3Y
-62%
5Y 5Y
-50%
10Y 10Y
-46%
Annual Price Range
10.32
52w Low
9.25
52w High
18.34
Price Metrics
Average Annual Return -5.4%
Standard Deviation of Annual Returns 26.61%
Max Drawdown -71%
Shares Statistics
Market Capitalization 3.3B HKD
Shares Outstanding 319 874 900
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

China Isotope & Radiation Corp

Country

China

Industry

Health Care

Market Cap

3.3B HKD

Dividend Yield

3.37%

Description

China Isotope & Radiation Corp. engages in the research, development, manufacturing and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products for medical and industrial applications. The company is headquartered in Beijing, Beijing. The company went IPO on 2018-07-06. The firm also provides radiation sterilization services. The firm is also involved in the design, manufacture and installation of Gama ray irradiation devices. The firm opeartes its businesse mainly through four segments, including the Pharmaceuticals segment, the Radiological Products segment, the Irradiation segment and the Independent Medical Laboratory Services and Others segment, with the Pharmaceuticals segment as the core segment. The Pharmaceuticals segment is engaged in the development, manufacture and sale of radiopharmaceuticals, the Kit for Urea Breath Test and testing instruments, as well as in vitro immunodiagnostic reagents and boxes for imaging diagnosis and treatment.

Contact

BEIJING
Beijing
No. 66, Changwa Middle Street, Haidian District
+861068511807.0
http://www.china-isotope.com/

IPO

2018-07-06

Employees

2 986

Officers

GM & Executive Director
Mr. Hongchao Xu
Chief Engineer & Employee Representative Director
Mr. Jin Du
Executive Chairman
Mr. Junqi Zhang
Chief Accountant, Chief Legal Officer and Joint Company Secretary
Mr. Youquan Gui
Joint Company Secretary
Ms. Mei Ha Kam FCIS, FCS (PE)
Deputy General Manager
Mr. Guomin Fan

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is the Intrinsic Value of one China Isotope & Radiation Corp stock?

The intrinsic value of one China Isotope & Radiation Corp stock under the Base Case scenario is 21.94 HKD.

Is China Isotope & Radiation Corp stock undervalued or overvalued?

Compared to the current market price of 10.32 HKD, China Isotope & Radiation Corp is Undervalued by 53%.

ALPHA SPREAD
Join more than 130,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.